A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias. 1983

M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson

This report summarizes the results of a randomized, double-blind, parallel group, multicenter study which compared the antiarrhythmic activity and safety of oral disopyramide phosphate and oral quinidine sulfate. A total of 124 outpatients, whose pretreatment rates of ventricular and/or supraventricular arrhythmias were documented by ambulatory ECG recordings, were randomly assigned to receive either oral disopyramide or oral quinidine for the eight-week course of the study. Every two weeks, ten-hour ambulatory ECG recordings were obtained from each patient and blood was drawn to determine serum concentrations of assigned drug.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004206 Disopyramide A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties. Diisopyramide,Disopyramide Monohydrochloride,Disopyramide Phosphate,Disopyramide Phosphate (1:1),Disopyramide Phosphate (1:1), (+-)-Isomer,Disopyramide Phosphate (1:1), (R)-Isomer,Disopyramide Phosphate (1:1), (S)-Isomer,Disopyramide, (+-)-Isomer,Disopyramide, (R)-Isomer,Disopyramide, (S)-Isomer,Disopyramide, D-Tartrate (1:1), (S)-Isomer,Disopyramide, L-Tartrate (1:1), (R)-Isomer,Disopyramide, L-Tartrate (1:1), (S)-Isomer,Disopyramide, L-Tartrate (1:2), (+-)-Isomer,Disopyramide, L-Tartrate, (S)-isomer,Norpace,Palpitin,Palpitine,Rhythmodan,Ritmilen,Rythmilen,SC-13957,SC 13957,SC13957
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females

Related Publications

M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson
July 1987, Clinical cardiology,
M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson
May 1994, European journal of radiology,
M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson
January 1998, Journal of psychopharmacology (Oxford, England),
M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson
April 1985, American heart journal,
M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson
July 2003, Clinical therapeutics,
M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson
April 2005, Diabetic medicine : a journal of the British Diabetic Association,
M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson
January 1994, Journal of gastroenterology and hepatology,
M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson
June 1997, International journal of clinical practice,
M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson
May 1980, The New England journal of medicine,
M Arif, and J C Laidlaw, and C Oshrain, and P W Willis, and C H Nissen, and D J McDermott, and W S Smith, and A Karim, and R R Wilson
April 2017, Arthritis & rheumatology (Hoboken, N.J.),
Copied contents to your clipboard!